Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell TransplantationFrancisco M. Marty, Cyrus Badshah, Kathleen M. Mullane et al.|New England Journal of Medicine|2017Cited by 1.2k
A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory TractFrancisco M. Marty, Sanjeet Dadwal, Roy F. Chemaly et al.|Clinical Infectious Diseases|2019Cited by 76
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant RecipientsRoy F. Chemaly, Michael Boeckh, Sanjeet Dadwal et al.|Clinical Infectious Diseases|2019Cited by 75
Remdesivir Use in the Setting of Severe Renal Impairment: A Theoretical Concern or Real Risk?Natasha N. Pettit, Kathleen M. Mullane, Jennifer Pisano et al.|Clinical Infectious Diseases|2020Cited by 67
Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trialRolando Pajón, F. Schödel, Yamuna Devi Paila et al.|Nature Medicine|2022Cited by 36